Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
387.10
-60.40 (-13.50%)
Dec 19, 2024, 11:10 AM EST - Market open
Vertex Pharmaceuticals Operating Expense Breakdown
History
| Date | Research and Development | Selling, General, and Administrative | Acquired In-Process Research and Development | Change in Value of Contingent Consideration |
|---|---|---|---|---|
| Sep 29, 2024 | 3.46B | 1.46B | 4.56B | -49.60M |
| Jun 29, 2024 | 3.39B | 1.35B | 4.60B | -48.70M |
| Mar 31, 2024 | 3.21B | 1.24B | 256.80M | -49.80M |
| Dec 31, 2023 | 3.16B | 1.14B | 527.10M | -51.60M |
| Sep 29, 2023 | 3.03B | 1.03B | 531.90M | 500.00K |
| Jun 29, 2023 | 2.87B | 1.02B | 509.20M | -3.30M |
| Mar 30, 2023 | 2.68B | 970.60M | 460.60M | -51.90M |
| Dec 31, 2022 | 2.54B | 944.70M | 115.50M | -57.50M |
| Sep 29, 2022 | 2.41B | 995.50M | 221.10M | -61.30M |
| Jun 29, 2022 | 2.23B | 946.90M | 218.80M | -57.50M |
| Mar 30, 2022 | 2.08B | 926.20M | 1.12B | -6.70M |
| Dec 31, 2021 | 1.94B | 840.10M | 1.11B | -3.10M |
| Sep 29, 2021 | 1.84B | 733.74M | 985.10M | -600.00K |
| Jun 29, 2021 | 1.86B | 720.09M | 958.40M | - |
| Mar 30, 2021 | 1.84B | 717.30M | - | 7.60M |
| Dec 31, 2020 | 1.83B | 770.46M | - | 13.10M |
| Sep 29, 2020 | 1.84B | 753.89M | - | 14.10M |
| Jun 29, 2020 | 1.91B | 729.01M | - | 15.26M |
| Mar 30, 2020 | 1.86B | 693.71M | - | 6.06M |
| Dec 31, 2019 | 1.75B | 658.50M | - | 4.46M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.